Document is current
Any future updates will be listed below
-
Authors
Cao, Xiujuan
Wang, Xiaowen
Song, Jian
Su, Ya
Wang, Lizhen
Yin, Yong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82072094, 82072094, 82072094, 82072094, 82072094, 82072094)
Taishan Scholars Project of Shandong Province (Grant No. ts20171209, Grant No. ts20171209, Grant No. ts20171209, Grant No. ts20171209, Grant No. ts20171209, Grant No. ts20171209)
Nature Science Foundation of Shandong Province (Grant No. ZR2019LZL017, Grant No. ZR2019LZL017, Grant No. ZR2019LZL017, Grant No. ZR2019LZL017, Grant No. ZR2019LZL017, Grant No. ZR2019LZL017)
Oncology Precision Radiotherapy Peak Program -- Clinical Research Projec (Grant No.2021HZ81, Grant No.2021HZ81, Grant No.2021HZ81, Grant No.2021HZ81, Grant No.2021HZ81, Grant No.2021HZ81)
- License Information
-
More Information
Article History
Received: 19 November 2023
Accepted: 1 April 2024
First Online: 8 April 2024
Declarations
:
: The study complied with the principles set forth in the Declaration of Helsinki. The studies involving human participants were reviewed and approved by the ethics committee of Shandong Cancer Hospital and Institute. The patients/participants provided written informed consent to participate in this study.
: Not applicable.
: The authors declare no competing interests.
